Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Glioblastoma × Pemetrexed × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 179 Lung Neoplasms 65 Neoplasms 22 Mesothelioma, Malignant 14 Adenocarcinoma of Lung 14 Neoplasm Metastasis 12 Mesothelioma 11 Parkinson Disease 4, Autosomal Dominant Lewy Body 10 Head and Neck Neoplasms 9 Carcinoma 9 Breast Neoplasms 8 Recurrence 5 Ovarian Neoplasms 5 Adenocarcinoma, Bronchiolo-Alveolar 5 Small Cell Lung Carcinoma 4 Colorectal Neoplasms 4 Adenocarcinoma 4 Stomach Neoplasms 3 Squamous Cell Carcinoma of Head and Neck 3 Pancreatic Neoplasms 3 Lung Diseases 3 Carcinoma, Small Cell 3 Brain Neoplasms 3 Uterine Cervical Neoplasms 2 Triple Negative Breast Neoplasms 2 Thoracic Neoplasms 2 Solitary Fibrous Tumor, Pleural 2 Respiratory Tract Neoplasms 2 Osteosarcoma 2 Non-Squamous Non-Small Cell Lung Cancer 2

Interventions

Temozolomide 104 Bevacizumab 64 Radiotherapy 45 Radiation 21 Erlotinib Hydrochloride 12 pembrolizumab 10 Magnetic Resonance Spectroscopy 10 Lomustine 10 Vorinostat 9 Irinotecan 9 Nivolumab 8 Surgical Procedures, Operative 7 Radiotherapy, Intensity-Modulated 7 Immunoglobulin G 7 Disulfides 7 Sorafenib 6 Radiotherapy, Conformal 6 Radiosurgery 6 Drug Therapy 6 Carmustine 6 antineoplaston AS 2-1 5 antineoplaston A10 5 Granulocyte-Macrophage Colony-Stimulating Factor 5 Everolimus 5 veledimex 4 selinexor 4 sargramostim 4 cediranib 4 Dasatinib 4 Cilengitide 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡